Palisade Bio Participates in the Virtual Investor “What’s Your Story” Summer Spotlight On-Demand Conference

Q: Who is the CEO of Palisade Bio (PALI)?

JD Finley serves as the Chief Executive Officer of Palisade Bio.

Q: Where can investors watch Palisade Bio's (PALI) conference presentation?

The presentation is available on-demand at virtualinvestorco.com and on the Events page in the Investors section of palisadebio.com .

Rhea-AI Impact

(Moderate)

Rhea-AI Sentiment

(Neutral)

Rhea-AI Summary

Palisade Bio (NASDAQ:PALI), a clinical-stage biopharmaceutical company developing therapeutics for autoimmune, inflammatory, and fibrotic diseases, announced its participation in the Virtual Investor "What's Your Story" Summer Spotlight On-Demand Conference.

During the conference, CEO JD Finley shared insights about his career journey, his commitment to the company, and his enthusiasm for Palisade's development programs. The presentation is now accessible on-demand through virtualinvestorco.com and the company's investor relations website.

07/22/2025 - 08:45 AM

– Video webcast now available on-demand

Carlsbad, CA, July 22, 2025 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade”, “Palisade Bio”, or the “Company”), a clinical-stage biopharmaceutical company focused on developing and advancing novel therapeutics for patients living with autoimmune, inflammatory, and fibrotic diseases, today announced JD Finley Chief Executive Officer of Palisade Bio, participated in the Virtual Investor “What’s Your Story” Summer Spotlight On-Demand Conference.

As part of the event, Mr. Finley dove deeper into his dedication to the Company, how he got to where he is today and provided insight into why he is so passionate about the Company’s programs in development.

The on-demand video webcast is now available on virtualinvestorco.com as well as the Events page under the Investors section of the Company’s website (palisadebio.com).

About Palisade Bio

Palisade Bio is a clinical-stage biopharmaceutical company focused on developing and advancing novel therapeutics for patients living with autoimmune, inflammatory, and fibrotic diseases. The Company believes that by using a targeted approach with its novel therapeutics it will transform the treatment landscape. For more information, please go to www.palisadebio.com.

Investor Relations Contact

JTC Team, LLC
Jenene Thomas
908-824-0775
PALI@jtcir.com

FAQ

When did Palisade Bio (PALI) participate in the Virtual Investor Summer Spotlight Conference?

Palisade Bio participated in the Virtual Investor Summer Spotlight Conference with the on-demand video webcast becoming available on July 22, 2025.